1. Microorganisms. 2020 Jan 10;8(1):94. doi: 10.3390/microorganisms8010094.

Characterization of the Gut Microbiota of Individuals at Different T2D Stages 
Reveals a Complex Relationship with the Host.

Chávez-Carbajal A(1), Pizano-Zárate ML(2), Hernández-Quiroz F(1), Ortiz-Luna 
GF(3), Morales-Hernández RM(2), De Sales-Millán A(1), Hernández-Trejo M(4), 
García-Vite A(5), Beltrán-Lagunes L(6), Hoyo-Vadillo C(7), García-Mena J(1).

Author information:
(1)Departamento de Genética y Biología Molecular, Centro de Investigación y de 
Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México 07360, 
Mexico.
(2)Departamento de Nutrición y Bioprogramación, Instituto Nacional de 
Perinatología, Ciudad de México 11000, Mexico.
(3)Departamento de Peri y Posmenopausia, Instituto Nacional de Perinatología, 
Ciudad de México 11000, Mexico.
(4)Departamento de Neurolobiología del Desarrollo, Instituto Nacional de 
Perinatología, Ciudad de México 1100, Mexico.
(5)Módulo Integral de Atención al Paciente con Diabetes por Etapas, Clínica de 
Medicina Familiar "Gustavo A. Madero", I.S.S.S.T.E., Ciudad de México 07020, 
Mexico.
(6)Jefatura de Enseñanza e Investigación, Clínica de Medicina Familiar "Gustavo 
A Madero", I.S.S.S.T.E., Ciudad de México 07020, Mexico.
(7)Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados 
del Instituto Politécnico Nacional, Ciudad de Mexico 07360, Mexico.

In this work, we studied 217 Mexican subjects divided into six groups with 
different stages of glucose intolerance: 76 Controls (CO), 54 prediabetes (PRE), 
14 T2D no medication (T2D-No-M), 14 T2D with Metformin (T2D-M), 22 T2D with 
polypharmacy (T2D-P), and 37 T2D with polypharmacy and insulin (T2D-P+I). We 
aimed to determine differences in the gut microbiota diversity for each 
condition. At the phylum level, we found that Firmicutes and Bacteroidetes 
outline major changes in the gut microbiota. The gut bacterial richness and 
diversity of individuals in the T2D-No-M group were lesser than other groups. 
Interestingly, we found a significant difference in the beta diversity of the 
gut microbiota among all groups. Higher abundance was found for Comamonadaceae 
in PRE, and Sutterella spp. in T2D-No-M. In addition, we found associations of 
specific microbial taxa with clinical parameters. Finally, we report predicted 
metabolic pathways of gut microbiota linked to T2D-M and PRE conditions. 
Collectively, these results indicate that each group has specific predicted 
metabolic characteristics and gut bacteria populations for each phenotype. The 
results of this study could be used to define strategies to modulate gut 
microbiota through noninvasive treatments, such as dietary intervention, 
probiotics or prebiotics, and to improve glucose tolerance of individuals with 
prediabetes or T2D.

DOI: 10.3390/microorganisms8010094
PMCID: PMC7022408
PMID: 31936722

Conflict of interest statement: The authors declare no conflict of interest. The 
funders had no role in the design of the study; in the collection, analyses, or 
interpretation of data; in the writing of the manuscript, or in the decision to 
publish the results.
